$AEHR

Does he own it?

Multiple explicit first-person ownership statements: a Jan disclosure listing himself as owning it, repeatedly calling it "one of my long positions," and including it among names he says he owns personally. His Feb portfolio-weight post omits AEHR from the structured breakdown but notes his real book holds "random names like AEHR," implying a smaller untiered position. No explicit percent ever given.

His thesis

AEHR makes burn-in/stress-test equipment for AI chips, SiC, and silicon photonics. Thesis is a transition from years of R&D/qualification into high-volume production as multiple hyperscalers and AI/optical customers qualify its systems, analogous to AAOI's pre-ramp inflection. He argues markets misprice it by anchoring to trailing revenue instead of the H2-2026/2027 volume ramp, expecting a major rerating as production orders land. Frames it as a sub-$1B-turned-multibillion moonshot riding AI/CPO/SiPh bottlenecks.

How his view evolved

Started as one of several "under the radar" supply-chain moonshots, moved to a conviction long with a dedicated simplified thesis, then repeatedly took victory laps as it roughly tripled on hyperscaler and $41M production orders, later mentioning it less once the rerating played out (~$3.5B MC).

Key points

• Explicitly disclosed owning it and repeatedly called it a long position
• Thesis: qualification-to-volume inflection as hyperscalers order; ignore trailing revenue
• Tracked it from ~$800M to multi-billion MC, citing $14M/$41M orders as ramp confirmation

Derived from a holistic read of his public posts — paraphrased, never quoted. See his actual posts about $AEHR on X ↗